FY2025 EPS Estimate for Bath & Body Works Boosted by Analyst

Bath & Body Works, Inc. (NYSE:BBWI) – Analysts at Telsey Advisory Group upped their FY2025 earnings estimates for shares of Bath & Body Works in a note issued to investors on Tuesday, November 26th. Telsey Advisory Group analyst D. Telsey now expects that the company will earn $3.28 per share for the year, up from their previous estimate of $3.24. Telsey Advisory Group has a “Outperform” rating and a $42.00 price objective on the stock. The consensus estimate for Bath & Body Works’ current full-year earnings is $3.18 per share. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2025 earnings at $2.07 EPS, Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.59 EPS.

BBWI has been the topic of a number of other reports. Barclays raised their price target on Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a report on Tuesday. Wells Fargo & Company raised their target price on shares of Bath & Body Works from $32.00 to $38.00 and gave the company an “equal weight” rating in a research note on Tuesday. Raymond James decreased their price objective on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. The Goldman Sachs Group dropped their target price on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $41.88.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $35.23 on Wednesday. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99. The business’s fifty day moving average price is $30.69 and its two-hundred day moving average price is $35.74. The company has a market capitalization of $7.72 billion, a P/E ratio of 8.59, a PEG ratio of 1.14 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Insider Activity

In other news, CEO Gina Boswell purchased 6,000 shares of Bath & Body Works stock in a transaction that occurred on Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is currently owned by company insiders.

Institutional Trading of Bath & Body Works

Large investors have recently added to or reduced their stakes in the company. First Community Trust NA acquired a new position in shares of Bath & Body Works in the 2nd quarter valued at about $30,000. True Wealth Design LLC grew its position in Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after purchasing an additional 1,054 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its stake in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after buying an additional 900 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works in the 3rd quarter worth approximately $39,000. Finally, TD Private Client Wealth LLC boosted its stake in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.